HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Windyga Selected Research

vatreptacog alfa

11/2015Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicity.
8/2014Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfa.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J Windyga Research Topics

Disease

21Hemophilia A (Haemophilia)
11/2018 - 09/2004
11Hemorrhage
07/2018 - 01/2011
5von Willebrand Diseases (von Willebrand's Disease)
09/2016 - 01/2009
4Hemophilia B (Haemophilia B)
09/2014 - 05/2011
2Infections
07/2006 - 07/2005
1Immune System Diseases (Immune Disorders)
03/2017
1Neoplasms (Cancer)
03/2017
1Thrombocytopenia (Thrombopenia)
01/2016
1Type 3 von Willebrand Disease
01/2016
1Spontaneous Abortion (Miscarriage)
05/2013
1Thrombotic Thrombocytopenic Purpura
05/2013
1Pain (Aches)
05/2012
1Blood Coagulation Disorders
09/2007
1Ischemic Stroke
10/2001
1Venous Thromboembolism
11/2000

Drug/Important Bio-Agent (IBA)

6Factor VIII (Coagulation Factor VIII)IBA
07/2018 - 09/2004
4recombinant FVIIa (rFVIIa)FDA Link
11/2015 - 05/2012
3Prothrombin (Factor II)IBA
09/2016 - 11/2000
3Factor IX (Coagulation Factor IX)FDA LinkGeneric
09/2014 - 01/2014
26-pyruvoyltetrahydropterin synthase (PTPS)IBA
03/2017 - 09/2004
2sugar formulated recombinant FVIIIIBA
05/2016 - 01/2014
2Factor VIIa (Activated Factor VII)IBA
11/2015 - 01/2013
2AntibodiesIBA
11/2015 - 05/2010
2vatreptacog alfaIBA
11/2015 - 08/2014
2von Willebrand FactorIBA
06/2011 - 01/2009
1concizumabIBA
11/2018
1ThrombinFDA Link
07/2018
1Tranexamic Acid (AMCA)FDA Link
09/2016
1human F8 proteinFDA Link
05/2016
1Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric
01/2016
1Arginine Vasopressin (Argipressin)IBA
01/2016
1Pharmaceutical PreparationsIBA
11/2015
1AntigensIBA
01/2014
1anti-inhibitor coagulant complexIBA
09/2013
1ADAMTS13 ProteinIBA
05/2013
1factor VII clotting antigenIBA
01/2013
1BAY 86-6150IBA
05/2012
1recombinant factor VIII SQIBA
09/2010
1Factor XIII (Coagulation Factor XIII)IBA
09/2007
1Hepatitis B Surface Antigens (HBsAg)FDA Link
07/2006
1Surface Antigens (Surface Antigen)IBA
07/2006
1Blood Coagulation Factors (Coagulation Factor)IBA
07/2006
1DNA (Deoxyribonucleic Acid)IBA
07/2006
1Immunoglobulin A (IgA)IBA
07/2005
1LatexIBA
07/2005
1Immunoglobulin G (IgG)IBA
07/2005
1factor V LeidenIBA
10/2001
1Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
10/2001

Therapy/Procedure

9Therapeutics
01/2016 - 07/2005
2Operative Surgical Procedures
09/2016 - 05/2011
1Drug Tapering
09/2017
1Arthroplasty
11/2014
1Dental Care
05/2012
1Blood Transfusion (Blood Transfusions)
01/2011